Clinical Trial Update: Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating simultaneous gemcitabine-docetaxel adjuvant therapy with extended bisphosphonate and surveillance for breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Breast Neoplasms | Phase 3 | Status: COMPLETED